Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes

Autor: Muñoz-Hernandez, Liliana, Ortiz-Bautista, Raul J., Brito-Córdova, Griselda, Lozano-Arvizu, Francisco, Saucedo, Sharim, Pérez-Méndez, Oscar, Zentella-Dehesa, Alejandro, Dauteuille, Carolane, Lhomme, Marie, Lesnik, Philippe, Chapman, M.John, Kontush, Anatol, Aguilar Salinas, Carlos A.

Publikováno v: In Atherosclerosis October 2018 277:72-79

Optimizing the pharmacology of statins: characteristics of rosuvastatin

Autor: Chapman, M.John ^*, McTaggart, Fergus

Publikováno v: In Atherosclerosis (Supplements) (Component) 2002 2(4):33-37

Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia

Autor: Giral, Philippe ^*, Bruckert, Eric, Jacob, Nelly, Chapman, M.John, Foglietti, Marie-José, Turpin, Gérard

Publikováno v: In Atherosclerosis 2001 154(2):421-427

Lifestyle Intervention Enhances HDL Function among Patients with Metabolic Syndrome Only at Normal LDL-Cholesterol Plasma Levels

Autor: Hansel, Boris, Bonnefont-Rousselot, Dominique, Orsoni, Alexina, Bittar, Randa, Giral, Philippe, Roussel, Ronan, Marre, Michel, Mohammedi, Kamel, Bruckert, Eric, Chapman, M.John, Kontush, Anatol

Publikováno v: Journal of clinical lipidology
Journal of clinical lipidology, Elsevier, 2016, ⟨10.1016/j.jacl.2016.05.008⟩
Journal of clinical lipidology, 2016, 〈10.1016/j.jacl.2016.05.008〉
Journal of clinical lipidology, 2016, ⟨10.1016/j.jacl.2016.05.008⟩

International audience; BackgroundMetabolic syndrome (MetS) is associated with altered lipoprotein metabolism and impairment in the functionality of small, dense HDL particles secondary to compositional alterations.ObjectiveTo investigate the capacit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::534a5c18b0b7423d1f46502b2ec9a77e
https://hal.sorbonne-universite.fr/hal-01318482/file/Hansel_Lifestyle.pdf

Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment A long-term follow-up study

Autor: Sposito, Andrei C., Lemos, Pedro A., Santos, Raul D., Hueb, Whady, Vinagre, Carmen G.C., Quintella, Edgard, Carneiro, Otavio, Chapman, M.John, Ramires, Jose A.F., Maranhão, Raul C.

Publikováno v: Journal of the American College of Cardiology. (12):2225-2232

ObjectivesWe sought to verify whether the intravascular metabolism of chylomicron-like emulsion may predict the clinical evolution of patients with coronary artery disease (CAD) undergoing secondary prevention therapy of CAD.BackgroundCase-control st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::86f044f82226b0bf62b106d239d062d5